Rainbow Coral Corp (fka RBCC)

[QualityStocks]

Investment Highlights

-RBCC has acquired a new equity interest in Nano3D Biosciences, Inc. (n3D).

-n3D's nanoparticle technology could completely revolutionize cell research.

-RBCC is spearheading the most innovative scientific and medical breakthroughs in the $84.6 billion global biotech industry.

-U.S. biotech companies raised $25 billion in 2010--a 15-percent jump over the previous year's investment total, according to Ernst & Young.

-RBCC is joining the ranks of bioscience companies like Puma - a company that recently announced a private placement of 14.7 million shares of its common stock to investors, resulting in proceeds of $55 million.